Carbone C, Piro G, Tamburrino A, Mina MM, Zanini S, Tortora G, et al. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP. J Pancreas (Online) [Internet]. 2013 Sep. 15 [cited 2025 Apr. 21];14(5S):562. Available from: https://serena.sharepress.it/index.php/jop/article/view/1866